“The
Report PharmaPoint: Prophylactic Human Papillomavirus Vaccines -
Australia Drug Forecast and Market Analysis to 2022 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
The first prophylactic vaccine
for immunization against human papillomavirus (HPV) became available
in 2006. The Global
HPV Vaccines Market
is now well established, yet vaccine coverage rates amongst the
traditional target population of adolescent girls remain persistently
low. Initially HPV vaccines were developed and marketed solely to
protect against cervical cancer. In recent years the role of HPV in
other cancers has been increasingly recognized which has facilitated
a shift towards vaccinating a wider population, most significant has
been the inclusion of males in routine vaccine recommendations in
some countries. The current HPV vaccines market is dominated by one
major player, Mercks Gardasil, with GlaxoSmithKlines (GSKs) HPV
vaccine Cervarix providing the only competition. The introduction of
Mercks nine-valent vaccine (V503) is set to change the future
landscape of the HPV vaccines sector.
GlobalData expects HPV vaccine
coverage rates in Australia to remain relatively high throughout the
forecast period, driven by a successful school-based immunization
program. The inclusion of males in the school immunization program
from 2013 will drive the expansion of the HPV vaccines market over
the forecast period. GlobalData expects that following approval
Mercks nine-valent vaccine V503 will be quickly adopted into the
Australian school-based immunization program, and this will provide
an additional boost to HPV vaccine sales in Australia.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/210573
Scope
Overview
of Prophylactic Human Papillomavirus Vaccines including epidemiology,
etiology, symptoms, diagnosis, pathology and treatment guidelines as
well as an overview on the competitive landscape.
-
Detailed information on the key drugs in the Australia including
product description, safety and efficacy profiles as well as a SWOT
analysis.
-
Sales forecast for the top drugs in the Australia from 2012-2022.
-
Analysis of the impact of key events as well the drivers and
restraints affecting the Australia Prophylactic Human Papillomavirus
Vaccines disease market.
Reasons
to buy
-
Understand and capitalize by identifying products that are most
likely to ensure a robust return
-
Stay ahead of the competition by understanding the changing
competitive landscape for Prophylactic Human Papillomavirus Vaccines
-
Effectively plan your M&A and partnership strategies by
identifying drugs with the most promising sales potential
-
Make more informed business decisions from insightful and in-depth
analysis of drug performance
-
Obtain sales forecast for drugs from 2012-2022 in the Australia
Table
of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 11
3 Disease Overview 12
3.1 Etiology and
Pathophysiology 13
3.1.1 Etiology 13
3.1.2 Pathophysiology 13
3.2 Symptoms 15
4 Vaccination Recommendations
and Coverage Rates 17
4.1 Australia 17
4.1.1 Vaccination
Recommendations and Policies 17
4.1.2 Vaccination Coverage 17
4.1.3 Clinical Practice 19
5 Competitive Assessment 20
5.1 Overview 20
5.2 Strategic Competitor
Assessment 20
5.3 Product Profiles 22
5.3.1 Gardasil 22
5.3.2 Cervarix 28
6 Unmet Need and Opportunity 33
6.1 Overview 33
6.2 Protection against Multiple
HPV Types 34
6.2.1 Unmet Need 34
6.2.2 Gap Analysis 35
6.2.3 Opportunity 36
6.3 Vaccine Coverage Rates 36
6.3.1 Unmet Need 36
6.3.2 Gap Analysis 37
6.3.3 Opportunity 37
6.4 Perception of Vaccine
Safety 38
6.4.1 Unmet Need 38
6.4.2 Gap Analysis 39
6.4.3 Opportunity 39
6.5 Awareness of HPV
Vaccination 40
6.5.1 Unmet Need 40
6.5.2 Gap Analysis 40
6.5.3 Opportunity 41
6.6 Affordability of HPV
Vaccines 41
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment